======= EIF3L ======= == Gene Information == * **Official Symbol**: EIF3L * **Official Name**: eukaryotic translation initiation factor 3 subunit L * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51386|51386]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y262|Q9Y262]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EIF3L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EIF3L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619197|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre- initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF- 3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03011, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}. |Paf67| |viral translational termination-reinitiation| |viral translation| |eukaryotic 48S preinitiation complex| |formation of cytoplasmic translation initiation complex| |eukaryotic translation initiation factor 3 complex| |eukaryotic 43S preinitiation complex| |cytoplasmic translational initiation| |translation initiation factor activity| |cytoplasmic translation| |viral gene expression| |translational initiation| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |translation| |peptide biosynthetic process| |ribonucleoprotein complex biogenesis| |amide biosynthetic process| |peptide metabolic process| |viral process| |symbiotic process| |cellular amide metabolic process| |interspecies interaction between organisms| |cellular protein-containing complex assembly| |RNA binding| |organonitrogen compound biosynthetic process| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp515|PU-H71 1μM R08 exp515]]|-2.65| |[[:results:exp134|MS023 2μM R03 exp134]]|-2.59| |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.22| |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.18| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.04| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.94| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.85| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.73| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.73| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.73| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.7| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.74| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.82| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.03| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.13| ^Gene^Correlation^ |[[:human genes:e:eif3k|EIF3K]]|0.657| |[[:human genes:a:atp13a1|ATP13A1]]|0.488| |[[:human genes:b:bcl2l1|BCL2L1]]|0.467| |[[:human genes:s:smg7|SMG7]]|0.412| Global Fraction of Cell Lines Where Essential: 7/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|1/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/16| |ovary|0/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2154 * **Expression level (log2 read counts)**: 8.13 {{:chemogenomics:nalm6 dist.png?nolink |}}